Toshihiko Honkura Overview
- Firm
- I-nest Capital
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Med. Deal Size
-
- Med. Valuation
-
Toshihiko Honkura General Information
Biography
Mr. Toshihiko Honkura co-founded and served as Chief Executive Officer and President at Quantum Biosystems. He serves as a Partner at I-nest Capital. He represents the company as both president and CEO. After a genome research project at the University of Tokyo, he went on to gain ten years' hands-on experience in business management and investment analysis as a manager at McKinsey & Company and the Innovation Network Corporation of Japan (INCJ), a public-private Japanese fund. He has a master's degree in Analytical Biochemistry from the University of Tokyo and an MBA from Columbia University. The scientific and business management acumen he brings to the team affords the company excellent and tested leadership.
Contact Information
Address
- Shibuya Fukras, 17th Floor
- 1-2-3 Dogenzaka, Shibuya-ku
- Tokyo, 150-0043
- Japan
Toshihiko Honkura Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
I-nest Capital | Investor | Partner | Tokyo, Japan | Venture Capital |
Toshihiko Honkura Lead Partner on Deals (2)
Toshihiko Honkura has been the lead partner on 2 deals. Their latest deal was with Med Mirai, a other healthcare technology systems company. The deal was made for on 28-Jun-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Med Mirai | 28-Jun-2023 | Early Stage VC | Completed | Other Healthcare Technology Systems | Tokyo, Japan | |
Tsubame BHB | 25-Jul-2022 | Completed | Industrial Chemicals | Yokohama, Japan |
Toshihiko Honkura Network (9)
Portfolio Executives (7)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Tatsuya Onodera | Med Mirai | Founder, Chief Executive Officer & Board Member | 28-Jun-2023 | Tokyo, Japan |
Yasuhiro Kusunose | Tsubame BHB | Chief Project Officer | 25-Jul-2022 | Yokohama, Japan |
Tsubame BHB | Chief Technology Officer, Board Member, and Rsearch & Development Planning Department Head | 25-Jul-2022 | Yokohama, Japan | |
Tsubame BHB | Board Member & Auditior | 25-Jul-2022 | Yokohama, Japan | |
Tsubame BHB | Chief Financial Officer & Executive Officer | 25-Jul-2022 | Yokohama, Japan |
Fund Team Members (2)
Name | Investor | Fund | Fund Location |
---|---|---|---|
I-nest Capital | Tokyo, Japan | ||
I-nest Capital | Tokyo, Japan |
Toshihiko Honkura Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
I-Nest Fund I | I-nest Capital | Venture - General | Closed | 2020 |
Toshihiko Honkura FAQs
-
Who is Toshihiko Honkura?
Mr. Toshihiko Honkura co-founded and served as Chief Executive Officer and President at Quantum Biosystems.
-
How much does Toshihiko Honkura typically invest?
Toshihiko Honkura's median deal size is
. -
What is Toshihiko Honkura’s main position?
Toshihiko Honkura’s primary position is Partner.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »